Axim Biotechnologies Capital Expenditures (CapEx) Growth & History (AXIM)

Axim Biotechnologies's capital expenditures (capex) was $2,839 for fiscal 2024.

View full Axim Biotechnologies company overview

Axim Biotechnologies annual capital expenditures (capex) history

Axim Biotechnologies annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$2,839$2,839
20232023-12-31$0−$8,710
20222022-12-31$8,710−$31,785−78.49%
20212021-12-31$40,495−$56,829−58.39%
20202020-12-31$97,324
20162016-12-31$0−$16,780
20152015-12-31$16,780$16,780
20142014-12-31$0
20122012-12-31$100,000

Axim Biotechnologies capital expenditures (capex) trends

Between the periods ended 2012-12-31 and 2024-12-31, Axim Biotechnologies's capital expenditures (capex) decreased from $100,000 to $2,839, a change of −$97,161. The latest reported quarter, Q1 2024, shows $2,839.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Axim Biotechnologies source filings ↗

Community posts

It’s quiet here.

No posts about AXIM yet. Start the conversation.

Write the first post